Vivek K. Jayaraman
Chief Operating Officer chez CERUS CORPORATION
Fortune : 2 M $ au 31/03/2024
Profil
Vivek K.
Jayaraman is currently the Chief Operating Officer at Cerus Corp.
He previously worked as the Vice President-Global Marketing at Medtronic, Inc. and as the Vice President-Global Sales & Marketing at TriVascular, Inc. From 2014 to 2016, he served as the Head-Media Relations and VP-Global Sales & Marketing at Trivascular Technologies, Inc. He also held the position of Vice President-Commercial Operations at Trivascular2, Inc. from 2009 to 2011.
Mr. Jayaraman completed his undergraduate degree at the University of Michigan and obtained an MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CERUS CORPORATION
0,48% | 14/03/2024 | 878 653 ( 0,48% ) | 2 M $ | 31/03/2024 |
Postes actifs de Vivek K. Jayaraman
| Sociétés | Poste | Début |
|---|---|---|
| CERUS CORPORATION | Chief Operating Officer | 01/03/2020 |
Anciens postes connus de Vivek K. Jayaraman
| Sociétés | Poste | Fin |
|---|---|---|
| TRIVASCULAR TECHNOLOGIES INC | Investor Relations Contact | 01/02/2016 |
Trivascular2, Inc.
 Trivascular2, Inc. Medical SpecialtiesHealth Technology Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare. | Corporate Officer/Principal | 02/12/2011 |
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Sales & Marketing | - |
TriVascular, Inc.
 TriVascular, Inc. Medical SpecialtiesHealth Technology TriVascular, Inc. develops and manufactures medical devices. It provides devices and procedures for treating abdominal aortic aneurysms and endovascular grafts. The company was founded by Michael V. Chobotov, Robert G. Whirley, and Joseph W. Humphrey in 1998 and is headquartered in Irvine, CA. | Sales & Marketing | - |
Formation de Vivek K. Jayaraman
| University of Michigan | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CERUS CORPORATION | Health Technology |
| Entreprise privées | 4 |
|---|---|
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
TriVascular, Inc.
TriVascular, Inc. Medical SpecialtiesHealth Technology TriVascular, Inc. develops and manufactures medical devices. It provides devices and procedures for treating abdominal aortic aneurysms and endovascular grafts. The company was founded by Michael V. Chobotov, Robert G. Whirley, and Joseph W. Humphrey in 1998 and is headquartered in Irvine, CA. | Health Technology |
Trivascular Technologies, Inc.
 Trivascular Technologies, Inc. Medical SpecialtiesHealth Technology Trivascular Technologies, Inc. operates as a medical device company developing and commercializing technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company was founded on July 11, 2007 and is headquartered in Santa Rosa, CA. | Health Technology |
Trivascular2, Inc.
Trivascular2, Inc. Medical SpecialtiesHealth Technology Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare. | Health Technology |
